关节痛进展为银屑病关节炎的风险:临床评估与超声作为预后因素的作用
研究纳入1419例接受综合关节痛评估的患者,8.4%符合ARP-PsA标准(关节痛伴银屑病和/或家族史),该亚组中29%在一年内进展为银屑病关节炎。多因素分析显示银屑病合并家族史、能量多普勒超声滑膜炎、超声附着点病变及低压痛关节计数是进展的预测因素。
要点
- 1419例关节痛患者中8.4%符合ARP-PsA标准,该亚组一年内29%进展为银屑病关节炎。
- 基线差异包括家族史、银屑病病程、疼痛严重度、关节计数及X线和超声表现。
- 多因素分析显示银屑病合并家族史、能量多普勒滑膜炎、超声附着点病变及低压痛关节计数有预测意义。
核心结论
- ARP-PsA患者频率为8.4%,其中29%在一年内进展为银屑病关节炎。
- 研究识别了该进展的主要预测变量。
研究设计与样本
- 研究纳入接受综合关节痛评估项目的患者,ARP-PsA标准定义为关节痛伴银屑病和/或银屑病家族史且非皮肤科转诊,分析基线特征并评估一年时进展为银屑病关节炎的情况,采用多因素分析识别预测特征。
主要发现
- 1419例患者中8.4%符合ARP-PsA标准,该亚组中29%在一年内进展为银屑病关节炎。
- 进展组与未进展组的基线差异包括家族史、银屑病病程、疼痛严重度、关节计数及影像学表现(X线和超声)。
- 多因素分析显示银屑病合并银屑病家族史、能量多普勒超声滑膜炎、超声附着点病变发现及低压痛关节计数的组合具有预测意义。
关键数值与推荐
- ARP-PsA标准定义为关节痛伴银屑病和/或银屑病家族史且非皮肤科转诊。
- 1419例中8.4%符合ARP-PsA标准,该亚组一年内29%进展为银屑病关节炎。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Referral of patients from dermatology to rheumatology practices due to psoriasis is unnecessary delayed. Many times musculoskeletal symptoms are the first reason for consultation. We aimed to estimate the proportion of ARP-PsA (arthralgia with risk to progression) defined by patients with arthralgia and the presence of psoriasis and/or a family history. Also, identify clinical, laboratory and imaging prognostic factors of PsA progression within the ARP-PsA group over a one year follow-up period. METHODS: Patients were included in a comprehensive arthralgia evaluation program, with the ARP-PsA criteria defined as arthralgia with Pso and/or a family history of Pso, not referred from dermatology. Baseline characteristics were analysed, and the progression to PsA at one year was assessed. Multivariate analysis identified predictor features for progression. RESULTS: Of the 1419 patients, 8.4% met ARP-PsA criteria, and 29% of this subgroup developed PsA at one year. Baseline differences between those who developed PsA and those who did not included family history, Pso duration, pain severity, joint count and imaging findings (X-ray and ultrasound). Multivariate analysis revealed the predictive significance of a combination of Pso plus family history of psoriasis disease, synovitis by Power Doppler ultrasound, ultrasound enthesopathy findings and low tender joint count. CONCLUSION: The frequency of patients ARP-PsA was 8.4%, of whom 29% developed PsA at one year. The main predictor variables for this progression were identified.
引用
- Garcia-Salinas R, Magri S, Mareco J, et al. Arthralgia with risk of progression to psoriatic arthritis: role of clinical assessments and ultrasound as prognostic factors. Rheumatology (Oxford). 2025. PMID: 39404885. doi:10.1093/rheumatology/keae562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。